+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bunavail"

Global Opioid Use Disorder Market Report and Forecast 2024-2032 - Product Thumbnail Image

Global Opioid Use Disorder Market Report and Forecast 2024-2032

  • Report
  • December 2023
  • 168 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Bunavail is a medication used to treat opioid addiction disorders. It is a combination of buprenorphine and naloxone, two drugs that work together to reduce cravings and withdrawal symptoms associated with opioid addiction. Bunavail is administered as a sublingual film, which is placed under the tongue and allowed to dissolve. It is designed to provide a steady, controlled release of buprenorphine and naloxone over a period of time. Bunavail is used as part of a comprehensive treatment plan that includes counseling and other support services. The Bunavail market includes a variety of companies that manufacture and distribute the medication. These include Endo Pharmaceuticals, Inc., Mylan N.V., and Teva Pharmaceuticals USA, Inc. Other companies in the market include Akorn, Inc., Alvogen, Inc., and Lannett Company, Inc. Show Less Read more